DAVID, Jan, Ondrej HRADSKY, Petr JABANDŽIEV, Eva KLASKOVA, Helena JIRINCOVA and Jan LEBL. Impact of SARS-CoV-2 variants on the incidence of paediatric inflammatory multisystem syndrome (PIMS-TS). JOURNAL OF PAEDIATRICS AND CHILD HEALTH. HOBOKEN: WILEY, 2022, vol. 58, No 10, p. 1901-1903. ISSN 1034-4810. Available from: https://dx.doi.org/10.1111/jpc.16204.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Impact of SARS-CoV-2 variants on the incidence of paediatric inflammatory multisystem syndrome (PIMS-TS)
Authors DAVID, Jan (203 Czech Republic, guarantor), Ondrej HRADSKY (203 Czech Republic), Petr JABANDŽIEV (203 Czech Republic, belonging to the institution), Eva KLASKOVA (203 Czech Republic), Helena JIRINCOVA (203 Czech Republic) and Jan LEBL (203 Czech Republic).
Edition JOURNAL OF PAEDIATRICS AND CHILD HEALTH, HOBOKEN, WILEY, 2022, 1034-4810.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30209 Paediatrics
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.700
RIV identification code RIV/00216224:14110/22:00128210
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/jpc.16204
UT WoS 000862425800040
Keywords in English SARS-CoV-2 variants; paediatric inflammatory multisystem syndrome
Tags 14110317, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 2/2/2023 14:40.
Abstract
In Spring 2020, following temporary success during the first wave of the world-wide pandemic of the novel 2019 coronavirus disease (COVID-19) with very few positive cases, the Czech Republic (CZ) subsequently suffered from one of the highest incidences of individuals who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In March 2022, the cumulative number of positive cases reached almost 3.5 million (34.1% of the population). Individual pandemic waves in CZ were characterised with predominant genetic variants, namely: B.1.258 in the second wave in late 2020, alpha (B.1.1.7) in the third wave in early 2021, delta (B.1.617.2) in the fourth wave in late 2021, and finally Omicron (B.1.1.529) in the last wave in early 2022. At the same time, paediatricians faced paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). The incidence of PIMS-TS among SARS-CoV-2 positive children varies at around 0.3:1000. However, no data have been published on the impact of variants or lineages of SARS-CoV-2 on the occurrence of PIMS-TS. The aim of this study was to analyse the association between SARS-CoV-2 lineage and the incidence of PIMS-TS cases.
PrintDisplayed: 21/8/2024 18:21